Analysis of thrombotic factors in severe acute respiratory syndrome (SARS) patients

Ya Ping Wu; Ran Wei; Zhong Hua Liu; Biao Chen; Ton Lisman; Dao Ling Ren; Ji Ju Han; Zuo Li Xia; Fu Sheng Zhang; Wen Bo Xu; Klaus T. Preissner; Philip G. de Groot

doi:10.1160/TH05-12-0827

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2006; 96(01): 100-101
DOI: 10.1160/TH05-12-0827

Letters to the Editor

Schattauer GmbH

Analysis of thrombotic factors in severe acute respiratory syndrome (SARS) patients

Ya Ping Wu^*

¹Department of Medicine, Taishan Medical University, Tai-an, China

²Department of Haematology, University Medical Center Utrecht, Utrecht, The Netherlands

,

Ran Wei^*

¹Department of Medicine, Taishan Medical University, Tai-an, China

,

Zhong Hua Liu^*

³National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China

,

Biao Chen

⁴Department of Medicine, Xuanwu Hospital of Capital University of Medical Sciences, Beijing, China

,

Ton Lisman

²Department of Haematology, University Medical Center Utrecht, Utrecht, The Netherlands

,

Dao Ling Ren

¹Department of Medicine, Taishan Medical University, Tai-an, China

,

Ji Ju Han

¹Department of Medicine, Taishan Medical University, Tai-an, China

,

Zuo Li Xia

¹Department of Medicine, Taishan Medical University, Tai-an, China

,

Fu Sheng Zhang

⁵Department of Medicine, Taian Medical Center, Tai-an, China

,

Wen Bo Xu

³National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China

,

Klaus T. Preissner

⁶Institute for Biochemistry, Medical Faculty, Justus Liebig University, Giessen, Germany

,

Philip G. de Groot

²Department of Haematology, University Medical Center Utrecht, Utrecht, The Netherlands

› Author Affiliations

Abstract

Full Text

References

References
1 Ng KH. et al. Pulmonary artery thrombosis ina patient with severe acute respiratory syndrome. Postgrad Med J 2005; 81: e3.
2 Wu YP. et al. SARS in Hong Kong. N Engl J Med 2003; 349: 708-9.
3 Lang ZW. et al. A clinicopathological study of three cases of SARS. Pathology 2003; 35: 526-31.
4 Rezaie AR. Vitronectin functions as a cofactor for rapid inhibition of activated proteinC by plasminogen activator inhibitor-1. Implications for the mechanism of profibrinolytic action of activated protein C. J Biol Chem 2001; 276: 15567-70.
5 World Health Organization (WHO). Severe acute respiratory syndrome (SARS). Wkly Epidemiol Rec 2003; 78: 81-3.
6 Muller MP. et al. Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia?. Clin Infect Dis 2005; 40: 1079-86.
7 Greiner M. Two-graph receiver operating characteristic (TG-ROC): update version supports optimisation of cut-off values that minimise overall misclassification costs. J Immunol Methods 1996; 191: 93-4.
8 CMDT Users Manual. Institute for Parasitology and Tropical Veterinary Medicine. Freie Universität; Berlin, Germany: Available by e-mail: cmdt@gmx.net.
9 Henderson AR. Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis. Ann Clin Biochem 1993; 30: 521-39.
10 Tang BS. et al. Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by SARScoronavirus and human coronavirus 229E. J Virol 2005; 79: 6180-93.
11 Wada H. et al. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Am J Hematol 2003; 72: 1-7.
12 Lijnen HR. Pleiotropic functions of plasminogen activator inhibitor-1. J Thromb Haemost 2005; 03: 35-45.
13 Chavakis T. et al. Inhibition of platelet adhesion and aggregation bya defined region (Gly-486-Lys-502) of high molecular weight kininogen. J Biol Chem 2002; 26: 23157-64.
14 Reheman A. et al. Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation. J Thromb Haemost 2005; 03: 875-83.
15 Wu YP. et al. Fibrin-incorporated vitronectin is involved in platelet adhesion and thrombus formation through homotypic interactions with platelet-associated vitronectin. Blood 2004; 104: 1034-41.